Clinical Trials Browser

Rectal Neoplasms

Colorectal Neoplasms

Urothelial Carcinoma of the Bladder

Carcinoma, Hepatocellular

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Small Bowel Adenocarcinoma

Rectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Borderline Resectable Pancreatic Adenocarcinoma

Colorectal Neoplasms

Head and Neck Neoplasms, Lung Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases

Liver Metastases From Colorectal Cancer (mCRC)

Oropharyngeal Neoplasms

Pancreatic Metastatic Cancer

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Clinical Stage 0 Gastric Cancer AJCC v8

Rectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Rectal Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Esophageal Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Esophageal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Pancreatic Neoplasms

Cholangiocarcinoma

Carcinoma, Non-Small-Cell Lung

Neoplasm Metastasis, Neoplasms

Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Stomach Neoplasms

Colorectal Neoplasms, Cholangiocarcinoma

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Peritoneal Neoplasms, Stomach Neoplasms

Colonic Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma, Klatskin Tumor

Biliary Tract Neoplasms, Gastrointestinal Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Rectal Neoplasms, Colorectal Neoplasms

Clinical Trials

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

FORBES

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

TNT Esophagus

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

CLEAR-02

ATATcH Alternating Treatment Plans for Advanced Cancer

GRACIE

VVSHIP

5-Fluorouracil Response and Optimization STudy (The FROST Trial)

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

PAMELA70

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer

Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer

TOGAR

LyRICX

Toco-CoR

Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer

PROTECT

FRUITFUL

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

PANCREAS

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer

METIMMOX

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

REDUCE

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

BBOpCo

STOPGAP

ERASE-CRC

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer